Citigroup Inc Mimedx Group, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Citigroup Inc holds 86,082 shares of MDXG stock, worth $798,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares

86,082

Previous 41,584 107.01%

Holding current value

$798,840

Previous $288,000 76.39%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.65 - $7.76 $251,413 - $345,304	44,498 Added 107.01%	86,082 $508,000
Q2 2024 Aug 12, 2024	SELL	$6.16 - $8.08 $2.23 Million - $2.93 Million	-362,291 Reduced 89.7%	41,584 $288,000
Q1 2024 May 10, 2024	BUY	$7.61 - $8.63 $2.29 Million - $2.6 Million	301,011 Added 292.63%	403,875 $3.11 Million
Q4 2023 Feb 09, 2024	BUY	$5.7 - $9.14 $46,842 - $75,112	8,218 Added 8.68%	102,864 $902,000
Q3 2023 Nov 09, 2023	BUY	$6.35 - $8.16 $139,547 - $179,324	21,976 Added 30.24%	94,646 $689,000
Q2 2023 Aug 10, 2023	SELL	$3.14 - $6.61 $205,924 - $433,490	-65,581 Reduced 47.44%	72,670 $480,000
Q1 2023 May 11, 2023	BUY	$2.97 - $4.81 $175,019 - $283,448	58,929 Added 74.29%	138,251 $471,000
Q4 2022 Feb 09, 2023	SELL	$2.63 - $3.45 $188,187 - $246,861	-71,554 Reduced 47.43%	79,322 $220,000
Q3 2022 Nov 10, 2022	BUY	$2.71 - $4.22 $93,530 - $145,644	34,513 Added 29.66%	150,876 $433,000
Q2 2022 Aug 10, 2022	BUY	$3.17 - $5.0 $244,933 - $386,330	77,266 Added 197.63%	116,363 $403,000
Q1 2022 May 12, 2022	SELL	$4.27 - $6.27 $640,517 - $940,525	-150,004 Reduced 79.32%	39,097 $184,000
Q4 2021 Feb 10, 2022	BUY	$5.7 - $8.48 $715,760 - $1.06 Million	125,572 Added 197.66%	189,101 $1.14 Million
Q3 2021 Nov 10, 2021	BUY	$5.52 - $15.83 $350,680 - $1.01 Million	63,529 New	63,529 $385,000

Others Institutions Holding MDXG

# of Institutions

209

Shares Held

98.2M

Call Options Held

Put Options Held

65.3K

View Full List

About MIMEDX GROUP, INC.

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.05B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

More about MDXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account